By combining tirzepatide , a dual-action GLP-1/GIP receptor agonist, with the amino acid glycine and vitamin B12 , this advanced formulation helps patients achieve their weight loss goals and feel stronger throughout the process
Sixty units on an insulin syringe always equals 0.6 mL of liquid
Day to day, the most common complaints are gastrointestinal, including nausea, vomiting, diarrhea, and constipation, and they tend to peak while the dose is being escalated
Stay in close communication with your healthcare provider throughout your treatment
Tirzepatide mimics both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), an additional hormone that enhances insulin sensitivity, reduces food intake, and increases fat metabolism